Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Macula Center is a specialized ophthalmic medical practice and clinical research center focused on the diagnosis and treatment of vitreoretinal diseases. Led by Dr. Dana M. Deupree, the center provides advanced surgical and medical interventions for conditions such as age-related macular degeneration, diabetic retinopathy, and retinal detachments. In addition to clinical care, the center actively participates in multi-center clinical trials, evaluating new pharmacological agents and surgical techniques. The facility is equipped with state-of-the-art diagnostic imaging, including optical coherence tomography and fluorescein angiography. By combining patient care with clinical research, The Macula Center offers access to emerging therapies for sight-threatening retinal disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Macula Center.